Krishnan KR (2007). "Revisiting monoamine oxidase inhibitors". Journal emsam inc. Clinical Psychiatry 68 (8). PMID 17640156.^ Patkar AA, Pae CU (May 2006). "Transdermal selegiline: the new generation of monoamine oxidase inhibitors". Journal of Clinical Psychopharmacology emsam inc. (3). PMID 9169972.^ Fiedorowicz.

trial". Journal of Clinical Psychopharmacology 17 (3). PMID emsam inc. (June 2007) "Continuous emsam inc. for Once-Daily Application". Bristol-Myers Squibb. Retrieved on 2007-09-15.^ emsam inc. Pharmaceuticals, Inc.,[22] The prescription medication is distributed by Bristol-Myers Squibb emsam inc. of Princeton NJ[edit] External linksEverything You Ever emsam inc. to Know about EMSAM and more. [1]FDA Approves Emsam (selegiline) as emsam inc. Drug Patch for Mood Disorders Approved". The Boston Globe.^ a b c d Patkar emsam inc. Pae CU, Zarzar M (2007). "Transdermal selegiline." Drugs of Today (Barcelona, Spain) Jun; 43(6): 361-77. [11]NIH Medication Information: EMSAM.NIH Medline Information: Serotonin Syndrome[edit] References^ a b Rapaport MH (2007). "Dietary restrictions and drug interactions with monoamine oxidase inhibitors in current psychiatric practice". Journal of Psychiatric Practice 10 (4). PMID 15552546.^ Krishnan KR (2007). "Revisiting monoamine oxidase inhibitors". Journal of Clinical Psychiatry 68 (8). PMID 17640156.^ Patkar AA, emsam inc. CU (May.

Diets". Journal of Clinical Psychiatry 67 (9). PMID 17017821.^ Serotonin Syndrome. Retrieved on 2007-09-14.^ Walker SE, emsam inc. KI, Tailor.